Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 7:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1753–1776 of 8,691 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Rhinoplasty, Pain Management
Interventions: Liposomal Bupivacaine, 0.25% bupivacaine with 1:200,000 epinephrine, Placebo - Saline solution; Drug · Other
Lead sponsor: Jessyka Lighthall; Other
Eligibility: 18 Years to 99 Years
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Hershey, Pennsylvania

Conditions: Primary Immunodeficiency Diseases (PID)
Interventions: TAK-881, HYQVIA; Biological
Lead sponsor: Takeda; Industry
Eligibility: 2 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 15
States / cities: Irvine, California • Walnut Creek, California • Denver, Colorado + 12 more

Conditions: End Stage Renal Disease, Inflammation
Interventions: Not listed
Lead sponsor: Fresenius Medical Care North America; Industry
Eligibility: 18 Years and older
Enrollment: 2,500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007
U.S. locations: 2
States / cities: Waltham, Massachusetts

Conditions: Frozen Embryo Pregnancy Rate
Interventions: Progesterone Vaginal Suppositories, Intramuscular Progesterone-in-Oil; Drug
Lead sponsor: Charles Coddington; Other
Eligibility: 20 Years to 50 Years · Female only
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Prostate Cancer
Interventions: Lower-Carbohydrate Med-t-Diet, Low-Fat Med-t-Diet; Other
Lead sponsor: Case Comprehensive Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Chronic Illness, Opioid Use, Palliative Care
Interventions: Clinical Decision Support System; Other
Lead sponsor: Hospice of Henderson County, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: New York, New York • Flat Rock, North Carolina

Conditions: Heart Attack, NSTEMI
Interventions: AMI MultiStem cells, Sham; Biological · Other
Lead sponsor: Healios K.K.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2020
U.S. locations: 11
States / cities: Birmingham, Alabama • Huntsville, Alabama • Los Angeles, California + 8 more

Conditions: Hyperlipidemia, Hypercholesterolemia
Interventions: Niacin, Colestipol, Ezetimibe; Drug
Lead sponsor: Tuscaloosa Research & Education Advancement Corporation; Other
Eligibility: 50 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Tuscaloosa, Alabama

Conditions: Rib Fracture
Interventions: Resection with or without plate fixation; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Peyronie's Disease
Interventions: H-100, Placebo; Drug
Lead sponsor: Hybrid Medical; Industry
Eligibility: 18 Years to 70 Years · Male only
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: Robbinsdale, Minnesota

Conditions: Fractures, Bone, Fracture Multiple
Interventions: Biomet Cannulated Screw: 3.0, 4.0, 5.0, 6.5, and 8.0mm screws.; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years and older
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2026
U.S. locations: 3
States / cities: Warsaw, Indiana • Worthington, Ohio • Lake Ridge, Virginia

Conditions: Pulmonary Embolism, Right Ventricular Dysfunction, Right Ventricular Failure
Interventions: Ultrasound-facilitated, catheter-directed lower-dose fibrinolysis, Tissue Plasminogen Activator; Device · Drug
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Infection
Interventions: Not listed
Lead sponsor: Oxford Immunotec; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2017
U.S. locations: 10
States / cities: Duarte, California • Los Angeles, California • Chicago, Illinois + 7 more

Conditions: Kidney Diseases, Arteriovenous Fistula
Interventions: EchoMark / EchoSure; Device
Lead sponsor: Sonavex, Inc.; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 4
States / cities: Dothan, Alabama • Peoria, Arizona • Flint, Michigan + 1 more

Conditions: Spondyloarthritis, Spondylarthropathy, Spondylitis, Ankylosing
Interventions: Not listed
Lead sponsor: Charite University, Berlin, Germany; Other
Eligibility: 18 Years and older
Enrollment: 992 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2013
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Prostate Cancer
Interventions: exisulind, conventional surgery, neoadjuvant therapy; Drug · Procedure
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 40 Years and older · Male only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 3
States / cities: Scottsdale, Arizona • Jacksonville, Florida • Rochester, Minnesota

Conditions: Non Small Cell Lung Cancer, Cardiotoxicity, Locally Advanced Non-Small Cell Lung Cancer, Radiation Therapy
Interventions: PET/CT 18F-Flurpiridaz Rest/Stress Test, Coronary CT Angiography (CCTA), 18F-Flurpiridaz; Diagnostic Test · Device · Drug
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: ADHD
Interventions: ADHD Therapy; Device
Lead sponsor: Lumos Labs, Inc.; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 194 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 5
States / cities: Jacksonville, Florida • Lakeland, Florida • Rochester Hills, Michigan + 2 more

Conditions: Lung Transplant, Organ Preservation
Interventions: Lung transplantation after 10°C donor lung preservation, Lung transplantation after standard ice cooler donor lung preservation; Device
Lead sponsor: University Health Network, Toronto; Other
Eligibility: 18 Years to 80 Years
Enrollment: 317 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 7
States / cities: Phoenix, Arizona • San Francisco, California • Coral Gables, Florida + 4 more

Conditions: Tooth Loss
Interventions: xenograft (BioOss Collagen); Device
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 95 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Lymphoma
Interventions: cyclophosphamide, etoposide, BCNU; Drug
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 15 Years to 55 Years
Enrollment: 147 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2010
U.S. locations: 2
States / cities: Fort Myers, Florida • Tampa, Florida

Conditions: Pelvic Organ Prolapse
Interventions: Uphold Lightweight Vaginal Support System, Traditional native tissue repair; Device · Procedure
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years to 100 Years · Female only
Enrollment: 289 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2020
U.S. locations: 28
States / cities: Birmingham, Alabama • Montgomery, Alabama • La Jolla, California + 23 more

Conditions: Colorectal Cancer
Interventions: Standard Inspection Colonoscopy, Dual Inspection Colonoscopy; Procedure
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 80 Years
Enrollment: 768 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Prostate Cancer
Interventions: Androgen deprivation therapy; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2006
U.S. locations: 2
States / cities: Boston, Massachusetts

Search by objective public record fields.

Efficacy of Liposomal Bupivacaine Post Septorhinoplasty

A Study About How TAK-881 is Processed by the Body and Side Effects in People With Primary Immunodeficiency Diseases

Inflammation and Nutritional Parameters in Hemodialysis Patients Using Reprocessed Dialyzers

Progesterone Support of FET

Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer

Characteristics and Clinical Implications of a Clinical Decision Support System

A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction

A Prospective, Open Label Comparison of Ezetimibe, Niacin, and Colestipol as Adjunct Therapy in Lipid Reduction

Evaluation of Surgical Treatment on Pain and Disability for Chronic, Non-healing Rib Fracture

Peyronie's Disease Treatment Protocol

MDR - Biomet Cannulated Screws

Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE

Observational Trial to Evaluate Hematopoietic Stem Cell Transplantation CMV Reactivation

Prospective Feasibility Study Evaluating EchoMark LP Placement and EchoSure Measurements for Subjects Requiring Arteriovenous Fistulae

Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA)

Neoadjuvant Exisulind in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage II or Stage III Prostate Cancer

Prospective Study on Radiation Induced Cardiotoxicity Assessed By PET-CT for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

An Adjunct Study to Assess Guided ADHD Therapy for Managing the Extent and Severity of Symptoms

10°C vs 4°C Lung Preservation RCT

Healing Dynamics in Human Extraction Sockets Grafted With Bio-Oss Collagen®

Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease

Uphold LITE Post-Market Surveillance Study

A Comparison of Methods to Detect Polyps During Colonoscopy

Prospective Study of Insulin Resistance and Cardiovascular Disease Risk During Androgen Deprivation Therapy for Prostate Cancer